Regulatory Solutions to the Problem of High Generic Drug Costs
Citation
Luo, Jing, Ameet Sarpatwari, and Aaron S. Kesselheim. 2015. “Regulatory Solutions to the Problem of High Generic Drug Costs.” Open Forum Infectious Diseases 2 (4): ofv179. doi:10.1093/ofid/ofv179. http://dx.doi.org/10.1093/ofid/ofv179.Abstract
Recent reports have highlighted dramatic price increases for several older generic drugs, including a number of essential products used to treat deadly infectious diseases. Although most of these medicines have been widely available at reasonable prices for decades, some manufacturers have seized on unique features of the pharmaceutical marketplace to seek substantial profits. In this Perspective, we examine limitations in current price regulation among public and private payors and consider several reforms that could address the problem of expensive generic drugs through improved competition.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685151/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:23993703
Collections
- HMS Scholarly Articles [17935]
- SPH Scholarly Articles [6362]
Contact administrator regarding this item (to report mistakes or request changes)